Market Overview

According to fortune business insights, the global molecular imaging market size was valued at USD 2.32 billion in 2025. The market is projected to grow from USD 2.45 billion in 2026 to USD 3.92 billion by 2034, exhibiting a CAGR of 6.05% during the forecast period. North America dominated the molecular imaging market with a market share of 43.69% in 2025.

The analysis shows that the market is driven by the growing prevalence of chronic conditions such as cancer, neurological disorders, and cardiovascular diseases, which increases the demand for advanced diagnostic procedures. For instance, the National Cancer Institute (NCI) estimated that about 2.0 million new cancer cases would be diagnosed in the U.S. in 2024. Key players are focusing on R&D to introduce innovative products, such as advanced PET scanners, to meet this growing demand.

Major Players Profiled in the Market Report:

• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Corporation (Japan)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Bruker (U.S.)
• Lantheus Holdings, Inc. (U.S.)
• Segami Corporation (U.S.)

Segments

Growing Adoption of PET Scanners to Drive Segment Growth

Based on type, the market is classified into Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and others. The PET segment dominated the market, driven by the increasing prevalence of neurological disorders, a growing emphasis on early disease detection, and an expanding installed base of PET scanners globally.

Increasing Cancer Prevalence to Boost Oncology Segment Growth

By application, the market is divided into cardiology, oncology, orthopedics, gynecology, neurology, and others. The oncology segment held the dominant market share due to the rising prevalence of various cancers and a growing diagnosis rate, which drives the demand for advanced imaging in cancer care.

Shift in Patient Preference to Drive Diagnostic Imaging Centers Segment

Based on end-user, the market is segmented into hospitals, specialty clinics, diagnostic imaging centers, and others. The diagnostic imaging centers segment is expected to grow with a considerable CAGR, fueled by a shift in patient preference toward these centers for their convenience, easy accessibility, and reduced waiting times.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.